Ticker LaunchReverse merger · Completed · OCUP
Ocuphire Pharma, Inc.
Reverse merger with Rexahn Pharmaceuticals, Inc. (REXN)
Ocuphire Pharma, Inc. merged into Rexahn Pharmaceuticals, Inc. (REXN), a Nasdaq-listed clinical-stage biotech, in a reverse merger that takes the private company public. The deal was announced on Jun 17, 2020 and closed on Nov 5, 2020. The combined company trades as Ocuphire Pharma, Inc. (OCUP) on Nasdaq.
Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, with a late-stage clinical pipeline of ophthalmic drug candidates.
- Status
- Completed
- Private company
- Ocuphire Pharma, Inc.
- Public company
- Rexahn Pharmaceuticals, Inc. (REXN)
- Public company business before
- Nasdaq-listed clinical-stage biotech
- Announced
- Jun 17, 2020
- Closed
- Nov 5, 2020
- Combined company
- Ocuphire Pharma, Inc. (OCUP)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Contingent value rights (CVR)
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- 8-K (merger completion) Nov 6, 2020
- Exhibit 99.1 (completion press release/exhibit)
- All filings on EDGAR CIK 1228627
Other completed reverse mergers
- F-star Therapeutics Limitedinto Spring Bank Pharmaceuticals, Inc. · Nov 20, 2020
- MedAvail, Inc.into MYOS RENS Technology Inc. · Nov 18, 2020
- Medi-Scan, Inc.into HYB Holding Corp. · Nov 16, 2020
- West Of Hudson Group, Inc.into Tongji Healthcare Group, Inc. · Nov 12, 2020
- QDM Holdings Limited (BVI)into 24/7 Kid Doc, Inc. (QDM International Inc.) · Oct 27, 2020
- Sigyn Therapeutics, Inc.into Reign Resources Corporation · Oct 19, 2020